Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
WHO Approves Sinovac’s CoronaVac for Children Aged 3 and Above
January 30, 2025
Policy / Regulatory
NHSA Orders Investigation into Unreasonable Medical Insurance Restrictions
January 27, 2025
Company
Drug
Fosun Pharma’s Avatrombopag Receives NMPA Review for Chronic ITP Indication
January 27, 2025
Company
Deals
Nanjing Pharmaceutical to Acquire Majority Stakes in Three Jiangsu Subsidiaries
January 27, 2025
Company
Deals
MSD and Kelun Biotech Ink Record-Breaking ADC Deal
January 27, 2025
Policy / Regulatory
NMPA and GAC Release Notification on Import and Export Management of Narcotic Drugs
January 27, 2025
Company
Drug
Shyndec’s Generic Cytosar-U Gains Marketing Approval in China
January 27, 2025
Company
Medical Device
Sino Medical Sciences’ NC Rockstar Catheter Approved by US FDA
January 27, 2025
Company
Drug
Antengene Files for Xpovio Approval in Macau, Malaysia, and Thailand
January 27, 2025
Drug
Eisai and Biogen Initiate BLA in China for Alzheimer’s Therapy Lecanemab
January 27, 2025
Company
Deals
Qitan Tech Raises RMB 700 Million in Series C Financing Led by Meituan
January 27, 2025
Company
Drug
Kanghong’s Escitalopram Oral Solution Receives NMPA Marketing Approval
January 27, 2025
1
2
…
1,065
1,066
1,067
1,068
1,069
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?